Top Markets
Coin of the day
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Classement en actions #17262
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Prix de l'action
$0.8799
Dernière synchronisation: 2026-09-01
Capitalisation boursière
$259.22M
Changement (1 jour)
-7.85%
Changement (1 an)
-14.57%
Pays
US
Échange Invivyd, Inc. (IVVD)

Catégorie

Historique des divisions d’actions pour Invivyd, Inc. (IVVD)
L’action Invivyd, Inc. (symbole : IVVD) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Sep 02, 2026.
Une action IVVD achetée avant le Sep 02, 2026 équivaudrait aujourd’hui à 0 actions IVVD.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH